Stanford L. Peng
Research Subjects
Research Interests
Stanford L. Peng has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
A. Pashine
Roche Palo Alto, Palo Alto, CA, USA
1 shared publicationD. Aud
Roche Palo Alto, Palo Alto, CA, USA
1 shared publicationDee Aud
Roche Palo Alto, Palo Alto, CA 94304, USA
1 shared publicationM. Li
Roche Palo Alto, Palo Alto, CA, USA
1 shared publicationM. R. Gubbels Bupp
Roche Palo Alto, Palo Alto, CA, USA
1 shared publicationXiaobo Wu
Washington University School of Medicine, St. Louis, Missouri, USA
1 shared publication
Latest Publications
- 1 January 2009
- Published by Elsevier in Autoimmunity Reviews
- Vol. 8 (3) , 179-183
Altered T and B lymphocyte signaling pathways in lupus
- 1 January 2009
- Published by Elsevier in Autoimmunity Reviews
- Vol. 8 (3) , 179-183
Altered T and B lymphocyte signaling pathways in lupus
- 7 April 2008
- Published by Springer Nature in Oncogene
- Vol. 27 (16) , 2337-2344
Foxo in the immune system
In addition to their key roles in cellular survival, death, proliferation and metabolism, the Foxo subfamily of forkhead (Fox) transcription factors play critical roles in the homeostasis of immune-relevant cells, including T cells, B cells, neutrophils and other non-lymphoid lineages that modulate inflammation in disease states such as inflammatory arthritis and systemic lupus erythematosus. This review summarizes such current and expanding knowledge of the Foxo family members in immunity, and their potential as therapeutic targets in inflammatory disease.
- 7 April 2008
- Published by Springer Nature in Oncogene
- Vol. 27 (16) , 2337-2344
Foxo in the immune system
In addition to their key roles in cellular survival, death, proliferation and metabolism, the Foxo subfamily of forkhead (Fox) transcription factors play critical roles in the homeostasis of immune-relevant cells, including T cells, B cells, neutrophils and other non-lymphoid lineages that modulate inflammation in disease states such as inflammatory arthritis and systemic lupus erythematosus. This review summarizes such current and expanding knowledge of the Foxo family members in immunity, and their potential as therapeutic targets in inflammatory disease.
- 1 January 2008
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. ume (13) , 4218-40
Transcription factors in autoimmune diseases
Studies on the pathogenesis of autoimmune diseases have begun to delve into the molecular and cellular mechanisms, and transcription factors, as key regulators of immune effector cell development and function, have received growing attention. Their involvement has been investigated in immune cells, such as T and B lymphocytes, macrophages and neutrophils, but also end-organ tissues, such as synoviocytes, keratinocytes and epithelial cells, and has revealed particularly dominant roles for NF-kappaB, STAT and AP-1 family members. This review summarizes recent findings and current knowledge regarding the roles of transcription factors in autoimmunity, focusing on their role in pathogenesis, as evidenced by both biological and genetic studies, as well as the implications of these findings for anti-inflammatory therapies.
- 1 January 2008
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. ume (13) , 4218-40
Transcription factors in autoimmune diseases
Studies on the pathogenesis of autoimmune diseases have begun to delve into the molecular and cellular mechanisms, and transcription factors, as key regulators of immune effector cell development and function, have received growing attention. Their involvement has been investigated in immune cells, such as T and B lymphocytes, macrophages and neutrophils, but also end-organ tissues, such as synoviocytes, keratinocytes and epithelial cells, and has revealed particularly dominant roles for NF-kappaB, STAT and AP-1 family members. This review summarizes recent findings and current knowledge regarding the roles of transcription factors in autoimmunity, focusing on their role in pathogenesis, as evidenced by both biological and genetic studies, as well as the implications of these findings for anti-inflammatory therapies.
- Open Access
- 22 November 2007
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 47 (1) , 103-104
The candidate lupus susceptibility gene Ifi202a is largely dispensable for B-cell function
Sir, The transcriptional modulator Ifi202 has been implicated in the pathogenesis of lupus via genetic studies in the vicinity of the Nba2 locus [1]. It is a member of the interferon-inducible Ifi200 cluster of genes located on mouse chromosome 1, which bears homology to a cluster of three human chromosome 1 genes (MNDA, IFI 16 and AIM2 [2]), all of which share a largely conserved ∼200 amino acid domain and have been implicated in multiple cellular processes, including cellular proliferation and apoptosis, by virtue of their ability to modulate the activity of relevant transcriptional regulators such as p53 [3], Rb, E2F [4] and NF-κB [5]. In lupus, Ifi202 has been proposed to regulate apoptosis in B-cells, perhaps via modulation of p53 [1, 6], thereby contributing to the underlying B-cell hyperactivity that causes disease. In addition, Ifi202 appears to be up-regulated in response to IL-6, which has also been implicated in lupus pathogenesis [7], and may be a target of the lupus autoantibody response, at least in mice [8]. However, much of the evidence linking Ifi202 and lupus pathogenesis has remained largely correlative and is based upon studies with Nba2 congenic mice, where a non-coding single-nucleotide polymorphism (SNP) appears to modulate the expression of Ifi202 [1, 6].
- 22 November 2007
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 47 (1) , 103-104
Open AccessThe candidate lupus susceptibility gene Ifi202a is largely dispensable for B-cell function
Sir, The transcriptional modulator Ifi202 has been implicated in the pathogenesis of lupus via genetic studies in the vicinity of the Nba2 locus [1]. It is a member of the interferon-inducible Ifi200 cluster of genes located on mouse chromosome 1, which bears homology to a cluster of three human chromosome 1 genes (MNDA, IFI 16 and AIM2 [2]), all of which share a largely conserved ∼200 amino acid domain and have been implicated in multiple cellular processes, including cellular proliferation and apoptosis, by virtue of their ability to modulate the activity of relevant transcriptional regulators such as p53 [3], Rb, E2F [4] and NF-κB [5]. In lupus, Ifi202 has been proposed to regulate apoptosis in B-cells, perhaps via modulation of p53 [1, 6], thereby contributing to the underlying B-cell hyperactivity that causes disease. In addition, Ifi202 appears to be up-regulated in response to IL-6, which has also been implicated in lupus pathogenesis [7], and may be a target of the lupus autoantibody response, at least in mice [8]. However, much of the evidence linking Ifi202 and lupus pathogenesis has remained largely correlative and is based upon studies with Nba2 congenic mice, where a non-coding single-nucleotide polymorphism (SNP) appears to modulate the expression of Ifi202 [1, 6].
- 30 January 2007
- Published by Wiley in Arthritis & Rheumatism
- Vol. 56 (2) , 395-398
Translating regulatory t cells in rheumatoid arthritis: Revisiting the past?
- 30 January 2007
- Published by Wiley in Arthritis & Rheumatism
- Vol. 56 (2) , 395-398
Translating regulatory t cells in rheumatoid arthritis: Revisiting the past?
- 1 January 2007
- Published by Taylor & Francis in Autoimmunity
- Vol. 40 (6) , 462-469
Immune regulation by Foxo transcription factors
The Foxo subfamily of forkhead (Fox) transcription factors are mammalian homologues of the Caenorhabditis elegans DAF-16 longevity gene, and play key roles in cellular and organism survival, death, proliferation and metabolism. A growing body of evidence indicates that Foxo proteins furthermore play critical roles in immune cell homeostasis, modulating inflammation in some disease states such as inflammatory arthritis and systemic lupus erythematosus (SLE), via fundamental roles in T cells, B cells, neurophils and other myeloid lineages. This review summarizes current knowledge of the Foxo family members in general and in immunity, including their potential use as therapeutic targets.
- 1 January 2007
- Published by Taylor & Francis in Autoimmunity
- Vol. 40 (6) , 462-469
Immune regulation by Foxo transcription factors
The Foxo subfamily of forkhead (Fox) transcription factors are mammalian homologues of the Caenorhabditis elegans DAF-16 longevity gene, and play key roles in cellular and organism survival, death, proliferation and metabolism. A growing body of evidence indicates that Foxo proteins furthermore play critical roles in immune cell homeostasis, modulating inflammation in some disease states such as inflammatory arthritis and systemic lupus erythematosus (SLE), via fundamental roles in T cells, B cells, neurophils and other myeloid lineages. This review summarizes current knowledge of the Foxo family members in general and in immunity, including their potential use as therapeutic targets.
- 1 November 2006
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 2 (6) , 869-876
Interactions of Fox proteins with inflammatory transcription-factor pathways
The forkhead (Fox) protein family includes a wide diversity of 'winged helix' transcription factors, now known to play critical roles in immune homeostasis. Although Foxp3 remains the most widely studied member for its role in the development and/or function of regulatory T cells, which extrinsically modulate the activity of effector leukocytes, other family members, such as Foxj1, Foxo3a and Foxd1, have received growing attention for their importance in the cell-intrinsic regulation of immune homeostasis, especially in T cells, by antagonizing the activity of proinflammatory transcription-factor pathways, such as the nuclear factor-kappaB or nuclear factor of activated T-cell families. This review summarizes a present understanding of these factors in this context.
- 1 November 2006
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 2 (6) , 869-876
Interactions of Fox proteins with inflammatory transcription-factor pathways
The forkhead (Fox) protein family includes a wide diversity of 'winged helix' transcription factors, now known to play critical roles in immune homeostasis. Although Foxp3 remains the most widely studied member for its role in the development and/or function of regulatory T cells, which extrinsically modulate the activity of effector leukocytes, other family members, such as Foxj1, Foxo3a and Foxd1, have received growing attention for their importance in the cell-intrinsic regulation of immune homeostasis, especially in T cells, by antagonizing the activity of proinflammatory transcription-factor pathways, such as the nuclear factor-kappaB or nuclear factor of activated T-cell families. This review summarizes a present understanding of these factors in this context.
- 1 August 2006
- Published by Springer Nature in Nature Clinical Practice Rheumatology
- Vol. 2 (8) , 434-442
Mechanisms of Disease: transcription factors in inflammatory arthritis
There is increasing interest in the role of transcription factors in the pathogenesis of inflammatory arthritis. Biologic and genetic studies are adding to current knowledge, and revealing potential targets for anti-inflammatory therapies that aim to modulate transcription factor activity. Studies on the pathogenesis of inflammatory arthritides have begun to delve into the molecular and cellular mechanisms behind the development of these diseases, and transcription factors, as key regulators of immune-effector-cell development and function, have received growing attention. Their involvement in immune cells, such as T and B lymphocytes, macrophages and neutrophils, and cells from diseased tissues, such as synoviocytes, has been investigated, revealing dominant roles for members of the nuclear factor κB family, signal-transducer and activator of transcription family, and activator protein 1 family. This review summarizes recent findings and current knowledge regarding the roles of transcription factors in inflammatory arthritis, as evidenced by both biological and genetic studies, and discusses the relevance of these findings for anti-inflammatory therapies.
- 1 August 2006
- Published by Springer Nature in Nature Clinical Practice Rheumatology
- Vol. 2 (8) , 434-442
Mechanisms of Disease: transcription factors in inflammatory arthritis
There is increasing interest in the role of transcription factors in the pathogenesis of inflammatory arthritis. Biologic and genetic studies are adding to current knowledge, and revealing potential targets for anti-inflammatory therapies that aim to modulate transcription factor activity. Studies on the pathogenesis of inflammatory arthritides have begun to delve into the molecular and cellular mechanisms behind the development of these diseases, and transcription factors, as key regulators of immune-effector-cell development and function, have received growing attention. Their involvement in immune cells, such as T and B lymphocytes, macrophages and neutrophils, and cells from diseased tissues, such as synoviocytes, has been investigated, revealing dominant roles for members of the nuclear factor κB family, signal-transducer and activator of transcription family, and activator protein 1 family. This review summarizes recent findings and current knowledge regarding the roles of transcription factors in inflammatory arthritis, as evidenced by both biological and genetic studies, and discusses the relevance of these findings for anti-inflammatory therapies.
- 1 April 2006
- Vol. 3 (2) , 87-95
The T-box transcription factor T-bet in immunity and autoimmunity.
The T-box transcription factor T-bet (Tbx21) has emerged as a key regulator of type 1-like immunity, playing critical roles in the establishment and/or maintenance of effector cell fates in T and B lymphocytes, as well as dendritic cells and natural killer cells. Several autoimmune diseases, especially those classically considered related to T helper 1 (Th1) immunity, appear to require T-bet, at least as judged in mouse models. This review summarizes a current understanding of T-bet's role in immunity, as well as its importance in autoimmunity, with implications for therapeutic intervention.
- 1 April 2006
- Vol. 3 (2) , 87-95
The T-box transcription factor T-bet in immunity and autoimmunity.
The T-box transcription factor T-bet (Tbx21) has emerged as a key regulator of type 1-like immunity, playing critical roles in the establishment and/or maintenance of effector cell fates in T and B lymphocytes, as well as dendritic cells and natural killer cells. Several autoimmune diseases, especially those classically considered related to T helper 1 (Th1) immunity, appear to require T-bet, at least as judged in mouse models. This review summarizes a current understanding of T-bet's role in immunity, as well as its importance in autoimmunity, with implications for therapeutic intervention.
- Open Access
- 29 December 2005
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (1) , 336-342
Toll‐like receptor 9 signaling protects against murine lupus
Objective: Hypomethylated CpG–containing DNA, which is recognized by Toll‐like receptor 9 (TLR‐9), has been strongly implicated in the pathogenesis of autoantibody‐mediated diseases such as systemic lupus erythematosus. This study was undertaken to determine the role of TLR‐9 in the MRL/+ and MRL/lpr models of murine lupus.Methods: TLR‐9–deficient MRL mice were generated by backcrossing a TLR‐9–deficient allele against the MRL backgrounds by a speed congenic technique. Parameters of murine lupus were examined by routine methods. Regulatory T cell activity was assessed by autologous mixed lymphocyte reaction (AMLR), an in vitro assay for autoreactivity.Results: Surprisingly, TLR‐9–deficient animals of both the MRL/+ and the MRL/lpr backgrounds developed more severe lupus, as judged by anti‐DNA and rheumatoid factor autoantibodies, total serum Ig isotypes, lymphadenopathy, inflammatory infiltrates in the salivary gland and kidney, proteinuria, and mortality, in comparison with their TLR‐9–sufficient littermates. In vitro, regulatory T cells from TLR‐9–deficient animals were impaired in their ability to suppress the AMLR.Conclusion: In the MRL model of murine lupus, TLR‐9 signaling plays a protective role, perhaps by modulating the activity of regulatory T cells. These results contrast with findings of recent studies that implicate TLR‐9 in the pathogenesis of anti‐DNA responses, based in part on investigations in incompletely backcrossed TLR‐9–deficient MRL/lpr mice in vivo or transgenic B cells in vitro. The present results highlight the need for caution in the assessment of disease paradigms based on the study of isolated cell populations in vitro, as well as in vivo studies of knockout animals involving non‐ideal genetic models.
- 29 December 2005
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (1) , 336-342
Open AccessToll‐like receptor 9 signaling protects against murine lupus
Objective: Hypomethylated CpG–containing DNA, which is recognized by Toll‐like receptor 9 (TLR‐9), has been strongly implicated in the pathogenesis of autoantibody‐mediated diseases such as systemic lupus erythematosus. This study was undertaken to determine the role of TLR‐9 in the MRL/+ and MRL/lpr models of murine lupus.Methods: TLR‐9–deficient MRL mice were generated by backcrossing a TLR‐9–deficient allele against the MRL backgrounds by a speed congenic technique. Parameters of murine lupus were examined by routine methods. Regulatory T cell activity was assessed by autologous mixed lymphocyte reaction (AMLR), an in vitro assay for autoreactivity.Results: Surprisingly, TLR‐9–deficient animals of both the MRL/+ and the MRL/lpr backgrounds developed more severe lupus, as judged by anti‐DNA and rheumatoid factor autoantibodies, total serum Ig isotypes, lymphadenopathy, inflammatory infiltrates in the salivary gland and kidney, proteinuria, and mortality, in comparison with their TLR‐9–sufficient littermates. In vitro, regulatory T cells from TLR‐9–deficient animals were impaired in their ability to suppress the AMLR.Conclusion: In the MRL model of murine lupus, TLR‐9 signaling plays a protective role, perhaps by modulating the activity of regulatory T cells. These results contrast with findings of recent studies that implicate TLR‐9 in the pathogenesis of anti‐DNA responses, based in part on investigations in incompletely backcrossed TLR‐9–deficient MRL/lpr mice in vivo or transgenic B cells in vitro. The present results highlight the need for caution in the assessment of disease paradigms based on the study of isolated cell populations in vitro, as well as in vivo studies of knockout animals involving non‐ideal genetic models.